Patent · US Active

Reactive oxygen species scavengers and use for treating diseases

US11312703B2 · kind B2 · utility

0Cited by

2References

16Claims

0Family size

Assignee

XWPHARMA LTD. · KY

Inventors

Jia-Ning Xiang · Palo Alto, US
Zude Qi · 红钢城街道, CN
Dezheng Ning · 红钢城街道, CN
Xianbo Liu · 红钢城街道, CN

Key dates

Filing date	Nov 12, 2020
Grant date	Apr 26, 2022
Priority date	—
Expiry date	Nov 12, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of Formula (I), pharmaceutically acceptable salts thereof, and individual enantiomers or diastereomers thereof. Compositions and methods useful for treatment or suppression of diseases, developmental delays and symptoms related to oxidative stress.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.